1Acelajado M C,Calhoun D A. Resistant hypertension,seeondary hypertension,and hypertensive crises:diagnostic evaluation and treatment[J].Cardiology Clinics,2010,(04):639-654.
2Calhoun D A,Jones D,Textor S. Resistant hypertension:diagnosis,evaluation,and treatment.A scientific statement from the American heart association professional education committee of the council for high blood pressure research[J].Circulation,2008,(25):e510-e526.
5Doumas M,Faselis C,Papademetriou V. Renal sympathetic denervation and systemic hypertension[J].American Journal of Cardiology,2010,(04):570-576.
6Krum H,Schlaich M,Whitbourn R. Catheter-based renal sympathetic denervation for resistant hypertension:a multicentre safety and proof-of-principle cohort study[J].The Lancet,2009,(9671):1275-1281.
7Symplicity HTN-1 Investigators. Catheter-based renal sympathetic denervation for resistant hypertension:durability of blood pressure reduction out to 24 months[J].Hypertension,2011,(05):911-917.
8Symplicity HTN-2 Investigators. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial):a randomized controlled trial[J].The Lancet,2010,(9756):1903-1909.
9Scheffers I J,Kroon A A,Schmidli J. Novel baroreflex activation therapy in resistant hypertension:results of a European multi-center feasibility study[J].Journal of the American College of Cardiology,2010,(15):1254-1258.
10Bisognano J D,Bakris G,Nadim M K. Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension:results from the double-blind,randomized,placebo-controlled rheos pivotal trial[J].Journal of the American College of Cardiology,2011,(07):765-773.
